Medtronic Eyes Acquisitions in Cardiology and Neuroscience
Medtronic announced plans to pursue acquisitions in cardiology and neuroscience at the J.P. Morgan healthcare conference. The company aims to leverage its financial strength to diversify its portfolio.
Insights:
Medtronic plc announced at the J.P. Morgan healthcare conference that it is actively evaluating acquisition opportunities in the low- to mid-single-digit billions range, with a strategic focus on cardiology and neuroscience companies. This move marks a significant shift in the company's capital allocation strategy, aiming to diversify its portfolio and supplement internal R&D efforts.
